Perspective Therapeutics (CATX) Common Equity (2011 - 2026)
Perspective Therapeutics' Common Equity came in at $323.86 million for Q2 2026, up 21.9% from $265.69 million a year earlier but down 6.8% from the prior quarter.
Perspective Therapeutics (CATX) Common Equity (2011 - 2026) Analysis & Trends
At the end of FY2025, Perspective Therapeutics' Common Equity was $207.03 million, down 28.8% from FY2024.
- Common Equity carries a five-year compound annual growth rate of 105.0% (FY2020 to FY2025).
- Going back by year, Common Equity was $290.67 million in FY2024 (+286.6%), $75.18 million in FY2023 (+37.6%), $54.64 million in FY2022 and $67.41 million in FY2021.
- The five-year range for quarterly Common Equity is $54.64 million (Q4 2022) to $347.44 million (Q1 2026).
- Year-over-year, Common Equity increased in five of the last eight quarters, with growth averaging 63.7%.
- The fastest year-over-year change in Common Equity over five years came in Q4 2024 (growth of 286.6%), and the weakest in Q4 2025 (a decline of 28.8%).
- Business Quant data shows CATX's Common Equity at $347.44 million (Q1 2026), $207.03 million (Q4 2025) and $242.22 million (Q3 2025) in the three quarters before Q2 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 84.97 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | -5.94 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 41.98 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 41.95 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 50.37 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 11.69 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 11.83 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 85.49 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 20.25 Bn |
| 10 | Perspective Therapeutics | 285.22 Mn | 285.22 Mn | - | 323.86 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 323.86 Mn |
| Mar 31, 2026 | 347.44 Mn |
| Dec 31, 2025 | 207.03 Mn |
| Sep 30, 2025 | 242.22 Mn |
| Jun 30, 2025 | 265.69 Mn |
| Mar 31, 2025 | 284.65 Mn |
| Dec 31, 2024 | 290.67 Mn |
| Sep 30, 2024 | 328.47 Mn |
| Jun 30, 2024 | 341.00 Mn |
| Mar 31, 2024 | 229.89 Mn |
| Dec 31, 2023 | 75.18 Mn |
| Sep 30, 2023 | 98.77 Mn |
| Jun 30, 2023 | 108.65 Mn |
| Mar 31, 2023 | 118.03 Mn |
| Dec 31, 2022 | 54.64 Mn |
| Sep 30, 2022 | 57.70 Mn |
| Jun 30, 2022 | 61.28 Mn |
| Mar 31, 2022 | 63.20 Mn |
| Dec 31, 2021 | 64.39 Mn |
| Sep 30, 2021 | 65.76 Mn |
Perspective Therapeutics Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=CATX&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "CATX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=CATX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();